The ready-to-use and certified BIOMED 2019-nCoV Antigen Rapid Test is a lateral flow immunoassay based on latex immunochromatography technology. It uses the double antibody sandwich method for the qualitative detection of coronavirus SARS-CoV-2 antigen (nucleocapsid protein specific) in human nasopharyngeal and oropharyngeal swab specimens. All known variants including delta, omicron, lambda etc. are reliably detected.
The test result must, of course, be analyzed in conjunction with the clinical presentation, other diagnostic information and epidemiological information to determine the patient’s current infection status. Use only by appropriately trained healthcare professionals.
Advantages of the rapid test:
Performance data *
Pathogen | Sensitivity | Specificity |
---|---|---|
2019-nCoV Antigen rapid test | 93,8 % | 99,7 % |
SARS-CoV-2 and COVID-19
2019-nCoV-antigen rapid test
Ask for our 2019-n-CoV-antigen-rapid test and our other products without obligation by mail or phone. We will then send you an email with your non-binding offer for the desired products. Please note that we do not sell our products to private individuals, but only to medical institutions and medical professionals.